Remepy
Business Services · Israel · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Ramat Gan, Tel Aviv, IsraelWebsite
www.remepy.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Remepy
Remepy is Pioneering Hybrid Drugs. The company believes that in the future, software applications will become an integral part of treatments offered by Pharma companies in the form of Hybrid Drugs. These will include both a software component and a traditional drug component - influencing patients via Hybrid Mechanisms of Action. Remepy’s Digital Molecules are designed to be the software components within Hybrid Drugs. They are based on digital interventions and treatment protocols that are tailored to each medical condition and its corresponding drug. The Digital Molecules enhance brain functions that balance the patient's neuro-endocrine and neuro-immunological systems and boost brain neuroplasticity, in order to optimize drug performance. Remepy partners with pharma companies to bring Hybrid Drugs to market that will combine Remepy’s Digital Molecule and traditional drug components.Explore more
Remepy Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Remepy your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Remepy had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Remepy recently announced quarterly report
Funding: Get notified immidiatlly once Remepy has new funding data
Congratulate Masked Content for being promoted to Masked Content at Remepy
Check out if Remepy is spiking on competitors!
Website visits: Recent activity has been detected on your website
Remepy, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Remepy has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Remepy launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Remepy is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Remepy is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Remepy.
Remepy financials insights
Gather financial insights about Remepy, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Angel/Seed
$10M
Remepy Tech Stack
A closer look at the technologies used by Remepy
Most Recent Scoops
Open Position
Person-Based
Hiring Plans
Remepy has more open roles in Engineering & Technical than it has had at any time in the past 12 months.
Hiring Plans
Person-Based
Person-Based
Remepy News & Media
Remepy Announces Collaboration with Merck KGaA, Darmstadt Germany to Advance Hybrid Drugs Across Therapeutic Areas
NEW YORK, April 28, 2026 /PRNewswire/ -- Remepy, the pioneer of Hybrid Drugs, today announced a collaboration with Merck KGaA, Darmstadt Germany, a leading science and technology company, to explore the development of Hybrid Drugs across multiple therapeutic areas. The collaboration will...Remepy's Mobile App Shown to Rewire Brain, Modulate Immune System and Improve Mood in Adults with Subjective Cognitive Decline
RMPY-008 is the first app-based intervention to demonstrate rapid modulation of inflammatory blood biomarkers, acting like a digital antibody in just three weeks Finding from a study of 103 adults published in NPJ Digital Medicine, building on pilot findings published earlier this year in...
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Remepy
Sign Up For FreeTo access detailed company insights
Remepy is Pioneering Hybrid Drugs. The company believes that in the future, software applications will become an integral part of treatments offered by Pharma companies in the form of Hybrid Drugs. These will include both a software component and a traditional drug component - influencing patients via Hybrid Mechanisms of Action. Remepy’s Digital M... Read More
